ten,46 In the BELA trial, grade three or 4 thrombocytopenia, neutropenia, and anemia occurred
10,46 In the BELA trial, grade three or four thrombocytopenia, neutropenia, and anemia occurred in 14 , six , and 11 of bosutinib-treated patients, respectively.45 Once more, because of the…